AIT joined an Austrian delegation of 15 life science companies to Boehringer Ingelheim, Biberach in Germany. During the two day exhibition, the companies presented their innovations and services to decision makers of the Boehringer Ingelheim group.
Representatives the Molecular Diagnostic Team at AIT - Peter Amersdorfer, Business Development and Klemens Vierlinger, Bioinformatics discussed in B2B meetings with Boehringer Ingelheim representatives novel solutions for companion diagnostics as well as bioinformatic analysis tools for the assessment of omics technologies.
“Innovation has been the driver of growth for the family owned Boehringer Ingelheim company and this meeting has created an excellent starting point for the transfer of knowledge and expertise from which the delegation members of the Human Technology Styria Cluster and Boehringer Ingelheim can mutually benefit in the future”, Peter Amersdofer said.